MQS Management LLC Acquires Shares of 5,212 U.S. Physical Therapy, Inc. (NYSE:USPH)

MQS Management LLC purchased a new stake in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 5,212 shares of the company's stock, valued at approximately $377,000.

A number of other institutional investors have also made changes to their positions in the business. Point72 Asset Management L.P. acquired a new position in shares of U.S. Physical Therapy during the 4th quarter worth about $18,886,000. Raymond James Financial Inc. acquired a new position in shares of U.S. Physical Therapy during the 4th quarter worth about $6,240,000. Nuveen Asset Management LLC grew its position in shares of U.S. Physical Therapy by 95.9% during the 4th quarter. Nuveen Asset Management LLC now owns 120,893 shares of the company's stock worth $10,724,000 after buying an additional 59,190 shares during the period. Envestnet Asset Management Inc. grew its position in shares of U.S. Physical Therapy by 20.1% during the 4th quarter. Envestnet Asset Management Inc. now owns 299,791 shares of the company's stock worth $26,594,000 after buying an additional 50,163 shares during the period. Finally, Proficio Capital Partners LLC acquired a new position in shares of U.S. Physical Therapy during the 4th quarter worth about $3,526,000.

U.S. Physical Therapy Stock Up 1.0%

NYSE USPH traded up $0.70 during trading on Wednesday, hitting $73.86. The stock had a trading volume of 151,221 shares, compared to its average volume of 124,982. The company has a market capitalization of $1.12 billion, a PE ratio of 34.01, a P/E/G ratio of 3.58 and a beta of 1.44. The company's 50-day moving average price is $76.69 and its two-hundred day moving average price is $78.76. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.17 and a current ratio of 1.17. U.S. Physical Therapy, Inc. has a 12 month low of $62.77 and a 12 month high of $101.20.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its earnings results on Wednesday, May 7th. The company reported $0.48 EPS for the quarter, beating the consensus estimate of $0.46 by $0.02. U.S. Physical Therapy had a return on equity of 7.89% and a net margin of 4.57%. The firm had revenue of $183.79 million for the quarter, compared to analysts' expectations of $176.78 million. During the same quarter in the previous year, the business posted $0.51 EPS. The business's quarterly revenue was up 18.0% compared to the same quarter last year. As a group, sell-side analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, June 13th. Stockholders of record on Friday, May 23rd were paid a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.44%. The ex-dividend date was Friday, May 23rd. U.S. Physical Therapy's dividend payout ratio is currently 82.57%.

Analyst Ratings Changes

Several equities analysts recently issued reports on USPH shares. JPMorgan Chase & Co. decreased their price objective on U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a research report on Wednesday, March 19th. Barrington Research reiterated an "outperform" rating and issued a $98.00 price objective on shares of U.S. Physical Therapy in a research report on Tuesday, July 1st. JMP Securities reiterated a "market outperform" rating and issued a $113.00 price objective on shares of U.S. Physical Therapy in a research report on Tuesday, April 22nd. Finally, Wall Street Zen upgraded U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research report on Thursday, May 8th. Two investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, U.S. Physical Therapy has a consensus rating of "Moderate Buy" and an average target price of $109.00.

Insider Activity

In related news, Director Nancy Ham sold 400 shares of the business's stock in a transaction that occurred on Thursday, June 12th. The stock was sold at an average price of $78.01, for a total transaction of $31,204.00. Following the transaction, the director directly owned 2,594 shares of the company's stock, valued at approximately $202,357.94. The trade was a 13.36% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.00% of the stock is currently owned by corporate insiders.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.